Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In line with the global trend to have disease-related organizations be more patient-centric in their approach, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has made substantial progress incorporating patient research partners (PRP) into psoriatic arthritis and psoriasis research. Herein we summarize the involvement of PRP at the GRAPPA 2016 annual meeting. Plans for future PRP engagement were also discussed.

Original publication

DOI

10.3899/jrheum.170152

Type

Journal article

Journal

J rheumatol

Publication Date

05/2017

Volume

44

Pages

703 - 705

Keywords

GRAPPA, PATIENT CENTRICITY, PATIENT RESEARCH PARTNERS, PSORIASIS, PSORIATIC ARTHRITIS, Arthritis, Psoriatic, Dermatology, Humans, Patient Participation, Psoriasis, Rheumatology